While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Most people have missed a dose of prescription medication at some point. But if you are taking a glucagon-like peptide-1 drug ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

What if we tell you that you can try these foods which mimic the results of Ozempic, without the side effects or spending on ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

Lexaria Bioscience (LEXX) announces partial final results showcasing the tolerability and glycemic control efficacy findings from human study ...

The rise in medication usage for weight loss unlocks opportunities for innovation in health-focused products and ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

This latter finding is particularly noteworthy as unwanted GI impacts are generally the most commonly cited side effects of today's leading glucagon-like peptide-1 / glucose-dependent insulinotropic ...